bioRxivCancer BiologyPreprint
Maintaining oxidized H3 in heterochromatin is required for the oncogenic capacity of triple-negative breast cancer cells
G. Serra-Bardenys, T. V. Tian, E. Blanco, J. Querol, L. Pascual-Reguant, B. Morancho, M. Escorihuela, S. Segura-Bayona, G. Verde, R. Aiese Cigliano, A. Millanes-Romero, C. Jerónimo, P. Nuciforo, S. Simonetti, C. Viaplana, R. Dienstmann, C. Saura, V. Peg, T. H. Stracker, J. Arribas, J. Villanueva, L. Di Croce, A. García de Herreros, S. Peiró
Abstract
The histone modification of H3 oxidized at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase-like 2 (LOXL2) and is enriched in heterochromatin in triple-negative breast cancer (TNBC) cells. Although H3K4ox has been linked to the maintenance of compacted chromatin, the molecular mechanism underlying this maintenance is unknown. Here we show that H3K4ox is read by the CRL4B complex, leading to the ubiquitination of histone H2A through the E3 ligase RBX1. Finally, interactions between RUVBL1/2 and LOXL2 are involved in the incorporation of the histone variant H2A.Z, which plays an essential role in the mechanism controlling the dynamics of oxidized H3. Maintenance of H3K4ox in chromatin is essential for heterochromatin properties, and disruption of any of the members involved in this pathway blocks the oncogenic properties of TNBC cells.
- organism: human
- assay: ChIP-seq
- research focus: chromatin & epigenetic regulation
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduction of LOXL2-mediated H3K4 oxidation increases chromatin accessibility and promotes chemosensitivity of triple-negative breast cancer cells
J.P. Cebrià-Costa, L. Pascual-Reguant, … S. Peiró·bioRxiv·Sep 13, 2018
- ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer
- The BRD4S-LOXL2-MED1 interaction at the forefront of cell cycle transcriptional control in triple-negative breast cancer
L. Pascual-Reguant, T. V. Tian, … S. Sdelci·bioRxiv·May 27, 2022
- H3.1Cys96 oxidation by mitochondrial ROS promotes chromatin remodeling, breast cancer progression to metastasis and multi-drug resistance
F. R. Palma, F. T. Ogata, … M. G. Bonini·bioRxiv·Dec 1, 2022
- Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival
Sławomir Andrzejewski, Marie Winter, … Eugen Dhimolea·CellsPeer-reviewed·Oct 8, 2025
- The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple-negative breast cancer tumors
Wei Wang, Yeaji Kim, … Khalid Sossey‐Alaoui·bioRxiv·Sep 10, 2026